Nature Communications (Apr 2023)

Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket

  • Edward N. Schmidt,
  • Dimitra Lamprinaki,
  • Kelli A. McCord,
  • Maju Joe,
  • Mirat Sojitra,
  • Ayk Waldow,
  • Jasmine Nguyen,
  • John Monyror,
  • Elena N. Kitova,
  • Fahima Mozaneh,
  • Xue Yan Guo,
  • Jaesoo Jung,
  • Jhon R. Enterina,
  • Gour C. Daskhan,
  • Ling Han,
  • Amanda R. Krysler,
  • Christopher R. Cromwell,
  • Basil P. Hubbard,
  • Lori J. West,
  • Marianne Kulka,
  • Simonetta Sipione,
  • John S. Klassen,
  • Ratmir Derda,
  • Todd L. Lowary,
  • Lara K. Mahal,
  • Meghan R. Riddell,
  • Matthew S. Macauley

DOI
https://doi.org/10.1038/s41467-023-38030-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Immunomodulatory Siglecs are controlled by their glycoprotein and glycolipid ligands. Siglec-glycolipid interactions are often studied outside the context of a lipid bilayer, missing the complex behaviors of glycolipids in a membrane. Through optimizing a liposomal formulation to dissect Siglec–glycolipid interactions, it is shown that Siglec-6 can recognize glycolipids independent of its canonical binding pocket, suggesting that Siglec-6 possesses a secondary binding pocket tailored for recognizing glycolipids in a bilayer. A panel of synthetic neoglycolipids is used to probe the specificity of this glycolipid binding pocket on Siglec-6, leading to the development of a neoglycolipid with higher avidity for Siglec-6 compared to natural glycolipids. This neoglycolipid facilitates the delivery of liposomes to Siglec-6 on human mast cells, memory B-cells and placental syncytiotrophoblasts. A physiological relevance for glycolipid recognition by Siglec-6 is revealed for the binding and internalization of extracellular vesicles. These results demonstrate a unique and physiologically relevant ability of Siglec-6 to recognize glycolipids in a membrane.